Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

Michael Rafii, MD, PhD · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
alzheimerdisease
down syndrome (ds), down syndrome (trisomy 21), alzheimer disease, amyloid beta protein, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 869338
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.